Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022
25 January 2022 - 8:05AM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a
commercial stage biotechnology company that aims to translate the
genetics of the adaptive immune system into clinical products to
diagnose and treat disease, today announced it will report
financial results for the fourth quarter and full year 2021 after
market close on Tuesday, February 15, 2022. Company management will
webcast a corresponding conference call beginning at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the “Investors” section of the company website at:
www.adaptivebiotech.com. The webcast will be archived and available
for replay within 24 hours after the event.
About Adaptive
BiotechnologiesAdaptive Biotechnologies is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed to develop products in life sciences research,
clinical diagnostics and drug discovery. We have three commercial
products and a robust clinical pipeline to diagnose, monitor and
enable the treatment of diseases such as cancer, autoimmune
conditions and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE INVESTORSKarina
Calzadilla, Vice President, Investor Relations201-396-1687Carrie
Mendivil, Gilmartin Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIALaura
Cooper205-908-5603media@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024